awmsg logo



progesterone (Utrogestan® Vaginal)


Reference No. 2477

Publication date:
27/02/2014


Appraisal information

progesterone (Utrogestan® Vaginal) 200 mg vaginal capsules


Company: Marlborough Pharmaceuticals
BNF category: Endocrine system
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 26/02/2014

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, progesterone (Utrogestan® Vaginal®) cannot be endorsed for use within NHS Wales for the supplementation of the luteal phase during assisted reproductive technology (ART) cycles.
Statement of Advice (SOA)
Download